Cargando…

The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain

BACKGROUND: Tumour metastasis to the brain is a common and deadly development in certain cancers; 18–30 % of breast tumours metastasise to the brain. The contribution that gene silencing through epigenetic mechanisms plays in these metastatic tumours is not well understood. RESULTS: We have carried...

Descripción completa

Detalles Bibliográficos
Autores principales: Pangeni, Rajendra P., Channathodiyil, Prasanna, Huen, David S., Eagles, Lawrence W., Johal, Balraj K., Pasha, Dawar, Hadjistephanou, Natasa, Nevell, Oliver, Davies, Claire L., Adewumi, Ayobami I., Khanom, Hamida, Samra, Ikroop S., Buzatto, Vanessa C., Chandrasekaran, Preethi, Shinawi, Thoraia, Dawson, Timothy P., Ashton, Katherine M., Davis, Charles, Brodbelt, Andrew R., Jenkinson, Michael D., Bièche, Ivan, Latif, Farida, Darling, John L., Warr, Tracy J., Morris, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457099/
https://www.ncbi.nlm.nih.gov/pubmed/26052355
http://dx.doi.org/10.1186/s13148-015-0089-x
_version_ 1782374936992546816
author Pangeni, Rajendra P.
Channathodiyil, Prasanna
Huen, David S.
Eagles, Lawrence W.
Johal, Balraj K.
Pasha, Dawar
Hadjistephanou, Natasa
Nevell, Oliver
Davies, Claire L.
Adewumi, Ayobami I.
Khanom, Hamida
Samra, Ikroop S.
Buzatto, Vanessa C.
Chandrasekaran, Preethi
Shinawi, Thoraia
Dawson, Timothy P.
Ashton, Katherine M.
Davis, Charles
Brodbelt, Andrew R.
Jenkinson, Michael D.
Bièche, Ivan
Latif, Farida
Darling, John L.
Warr, Tracy J.
Morris, Mark R.
author_facet Pangeni, Rajendra P.
Channathodiyil, Prasanna
Huen, David S.
Eagles, Lawrence W.
Johal, Balraj K.
Pasha, Dawar
Hadjistephanou, Natasa
Nevell, Oliver
Davies, Claire L.
Adewumi, Ayobami I.
Khanom, Hamida
Samra, Ikroop S.
Buzatto, Vanessa C.
Chandrasekaran, Preethi
Shinawi, Thoraia
Dawson, Timothy P.
Ashton, Katherine M.
Davis, Charles
Brodbelt, Andrew R.
Jenkinson, Michael D.
Bièche, Ivan
Latif, Farida
Darling, John L.
Warr, Tracy J.
Morris, Mark R.
author_sort Pangeni, Rajendra P.
collection PubMed
description BACKGROUND: Tumour metastasis to the brain is a common and deadly development in certain cancers; 18–30 % of breast tumours metastasise to the brain. The contribution that gene silencing through epigenetic mechanisms plays in these metastatic tumours is not well understood. RESULTS: We have carried out a bioinformatic screen of genome-wide breast tumour methylation data available at The Cancer Genome Atlas (TCGA) and a broad literature review to identify candidate genes that may contribute to breast to brain metastasis (BBM). This analysis identified 82 candidates. We investigated the methylation status of these genes using Combined Bisulfite and Restriction Analysis (CoBRA) and identified 21 genes frequently methylated in BBM. We have identified three genes, GALNT9, CCDC8 and BNC1, that were frequently methylated (55, 73 and 71 %, respectively) and silenced in BBM and infrequently methylated in primary breast tumours. CCDC8 was commonly methylated in brain metastases and their associated primary tumours whereas GALNT9 and BNC1 were methylated and silenced only in brain metastases, but not in the associated primary breast tumours from individual patients. This suggests differing roles for these genes in the evolution of metastatic tumours; CCDC8 methylation occurs at an early stage of metastatic evolution whereas methylation of GANLT9 and BNC1 occurs at a later stage of tumour evolution. Knockdown of these genes by RNAi resulted in a significant increase in the migratory and invasive potential of breast cancer cell lines. CONCLUSIONS: These findings indicate that GALNT9 (an initiator of O-glycosylation), CCDC8 (a regulator of microtubule dynamics) and BNC1 (a transcription factor with a broad range of targets) may play a role in the progression of primary breast tumours to brain metastases. These genes may be useful as prognostic markers and their products may provide novel therapeutic targets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0089-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4457099
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44570992015-06-06 The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain Pangeni, Rajendra P. Channathodiyil, Prasanna Huen, David S. Eagles, Lawrence W. Johal, Balraj K. Pasha, Dawar Hadjistephanou, Natasa Nevell, Oliver Davies, Claire L. Adewumi, Ayobami I. Khanom, Hamida Samra, Ikroop S. Buzatto, Vanessa C. Chandrasekaran, Preethi Shinawi, Thoraia Dawson, Timothy P. Ashton, Katherine M. Davis, Charles Brodbelt, Andrew R. Jenkinson, Michael D. Bièche, Ivan Latif, Farida Darling, John L. Warr, Tracy J. Morris, Mark R. Clin Epigenetics Research BACKGROUND: Tumour metastasis to the brain is a common and deadly development in certain cancers; 18–30 % of breast tumours metastasise to the brain. The contribution that gene silencing through epigenetic mechanisms plays in these metastatic tumours is not well understood. RESULTS: We have carried out a bioinformatic screen of genome-wide breast tumour methylation data available at The Cancer Genome Atlas (TCGA) and a broad literature review to identify candidate genes that may contribute to breast to brain metastasis (BBM). This analysis identified 82 candidates. We investigated the methylation status of these genes using Combined Bisulfite and Restriction Analysis (CoBRA) and identified 21 genes frequently methylated in BBM. We have identified three genes, GALNT9, CCDC8 and BNC1, that were frequently methylated (55, 73 and 71 %, respectively) and silenced in BBM and infrequently methylated in primary breast tumours. CCDC8 was commonly methylated in brain metastases and their associated primary tumours whereas GALNT9 and BNC1 were methylated and silenced only in brain metastases, but not in the associated primary breast tumours from individual patients. This suggests differing roles for these genes in the evolution of metastatic tumours; CCDC8 methylation occurs at an early stage of metastatic evolution whereas methylation of GANLT9 and BNC1 occurs at a later stage of tumour evolution. Knockdown of these genes by RNAi resulted in a significant increase in the migratory and invasive potential of breast cancer cell lines. CONCLUSIONS: These findings indicate that GALNT9 (an initiator of O-glycosylation), CCDC8 (a regulator of microtubule dynamics) and BNC1 (a transcription factor with a broad range of targets) may play a role in the progression of primary breast tumours to brain metastases. These genes may be useful as prognostic markers and their products may provide novel therapeutic targets. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0089-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-05-27 /pmc/articles/PMC4457099/ /pubmed/26052355 http://dx.doi.org/10.1186/s13148-015-0089-x Text en © Pangeni et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pangeni, Rajendra P.
Channathodiyil, Prasanna
Huen, David S.
Eagles, Lawrence W.
Johal, Balraj K.
Pasha, Dawar
Hadjistephanou, Natasa
Nevell, Oliver
Davies, Claire L.
Adewumi, Ayobami I.
Khanom, Hamida
Samra, Ikroop S.
Buzatto, Vanessa C.
Chandrasekaran, Preethi
Shinawi, Thoraia
Dawson, Timothy P.
Ashton, Katherine M.
Davis, Charles
Brodbelt, Andrew R.
Jenkinson, Michael D.
Bièche, Ivan
Latif, Farida
Darling, John L.
Warr, Tracy J.
Morris, Mark R.
The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
title The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
title_full The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
title_fullStr The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
title_full_unstemmed The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
title_short The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
title_sort galnt9, bnc1 and ccdc8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457099/
https://www.ncbi.nlm.nih.gov/pubmed/26052355
http://dx.doi.org/10.1186/s13148-015-0089-x
work_keys_str_mv AT pangenirajendrap thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT channathodiyilprasanna thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT huendavids thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT eagleslawrencew thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT johalbalrajk thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT pashadawar thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT hadjistephanounatasa thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT nevelloliver thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT daviesclairel thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT adewumiayobamii thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT khanomhamida thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT samraikroops thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT buzattovanessac thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT chandrasekaranpreethi thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT shinawithoraia thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT dawsontimothyp thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT ashtonkatherinem thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT davischarles thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT brodbeltandrewr thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT jenkinsonmichaeld thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT biecheivan thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT latiffarida thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT darlingjohnl thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT warrtracyj thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT morrismarkr thegalnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT pangenirajendrap galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT channathodiyilprasanna galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT huendavids galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT eagleslawrencew galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT johalbalrajk galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT pashadawar galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT hadjistephanounatasa galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT nevelloliver galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT daviesclairel galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT adewumiayobamii galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT khanomhamida galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT samraikroops galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT buzattovanessac galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT chandrasekaranpreethi galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT shinawithoraia galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT dawsontimothyp galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT ashtonkatherinem galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT davischarles galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT brodbeltandrewr galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT jenkinsonmichaeld galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT biecheivan galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT latiffarida galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT darlingjohnl galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT warrtracyj galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain
AT morrismarkr galnt9bnc1andccdc8genesarefrequentlyepigeneticallydysregulatedinbreasttumoursthatmetastasisetothebrain